Trimedyne Inc (TMED) 0.0376 $TMED Trimedyne Rep
Post# of 273317
Posted On: 08/17/2016 9:05:26 AM
Trimedyne Inc (TMED) 0.0376 $TMED
Trimedyne Reports Its Financial Results for the Quarter and Six Months Ended March 31, 2016
ACCESSWIRE - Tue May 17, 8:02AM CDT
IRVINE, CA / ACCESSWIRE / May 17, 2016 / TRIMEDYNE, INC. (OTC: TMED) reported its financial results for the quarter and six month period ended March 31, 2016.
Trimedyne Reports its Financial Results for the Quarter and Nine Months Ended June 30, 2015
ACCESSWIRE - Fri Aug 14, 8:00AM CDT
IRVINE, CA / ACCESSWIRE / August 14, 2015 / TRIMEDYNE, INC. ("TMED"
, (PINKSHEETS: TMED), today reported its financial results for the quarter and nine-month period ended June 30, 2015.
Trimedyne Announces Changes in Management and Directors
ACCESSWIRE - Fri Feb 06, 8:15AM CST
IRVINE, CA / ACCESSWIRE / February 6, 2015 / Trimedyne, Inc. (OTC: TMED) (PINKSHEETS: TMED), announced that Marvin P. Loeb, Sc.D. asked to be relieved of the offices of Chairman of the Board and CEO of the Company, due to his age and a recent injury temporarily limiting his mobility, effective January 30, 2015. This resignation was not a result of any disagreement with the Company, its management, the Company's Board or any matter relating to the Company's operations, policies or practices. In addition, Dr. Loeb was elected to the office of Chief Scientific Officer of the Company at his current cash compensation, and remains a member of the Board of Directors of the Company.
Trimedyne Reports Financial Results for the Quarter and Fiscal Year Ended September 30, 2014
ACCESSWIRE - Fri Jan 16, 8:15AM CST
LAKE FOREST, CA / ACCESSWIRE / January 16, 2015 / Trimedyne, Inc. (OTCQB: TMED) reported revenues of $5,461,000 for the fiscal year ended September 30, 2014, an 8.8% decrease from revenues of $5,989,000 for the prior fiscal year. The decrease was primarily due to the delay in shipments of Fibers, Needles and Switch Tips to our customers, resulting from our relocation to our smaller manufacturing facility in Irvine, California.
Trimedyne Reports Its Financial Results for the Quarter and Six Months Ended March 31, 2016
ACCESSWIRE - Tue May 17, 8:02AM CDT
IRVINE, CA / ACCESSWIRE / May 17, 2016 / TRIMEDYNE, INC. (OTC: TMED) reported its financial results for the quarter and six month period ended March 31, 2016.
Trimedyne Reports its Financial Results for the Quarter and Nine Months Ended June 30, 2015
ACCESSWIRE - Fri Aug 14, 8:00AM CDT
IRVINE, CA / ACCESSWIRE / August 14, 2015 / TRIMEDYNE, INC. ("TMED"
, (PINKSHEETS: TMED), today reported its financial results for the quarter and nine-month period ended June 30, 2015. Trimedyne Announces Changes in Management and Directors
ACCESSWIRE - Fri Feb 06, 8:15AM CST
IRVINE, CA / ACCESSWIRE / February 6, 2015 / Trimedyne, Inc. (OTC: TMED) (PINKSHEETS: TMED), announced that Marvin P. Loeb, Sc.D. asked to be relieved of the offices of Chairman of the Board and CEO of the Company, due to his age and a recent injury temporarily limiting his mobility, effective January 30, 2015. This resignation was not a result of any disagreement with the Company, its management, the Company's Board or any matter relating to the Company's operations, policies or practices. In addition, Dr. Loeb was elected to the office of Chief Scientific Officer of the Company at his current cash compensation, and remains a member of the Board of Directors of the Company.
Trimedyne Reports Financial Results for the Quarter and Fiscal Year Ended September 30, 2014
ACCESSWIRE - Fri Jan 16, 8:15AM CST
LAKE FOREST, CA / ACCESSWIRE / January 16, 2015 / Trimedyne, Inc. (OTCQB: TMED) reported revenues of $5,461,000 for the fiscal year ended September 30, 2014, an 8.8% decrease from revenues of $5,989,000 for the prior fiscal year. The decrease was primarily due to the delay in shipments of Fibers, Needles and Switch Tips to our customers, resulting from our relocation to our smaller manufacturing facility in Irvine, California.
(0)
(0)